It’s not “probably nothing,” it is nothing. How LCY is structured as a business has nothing to do with BioAmber whatsoever. The use of a confidentiality agreement during a bidding process is not uncommon, and it sure doesn’t mean “we’re going to show a purchase price of $4.34M and keep the juicy $540M out of public, creditor, and judicial view (wink wink).” The terms and price of the liquidation transaction were disclosed over a year and a half ago.